Key result
In a registry of 42 Japanese patients with non-valvular atrial fibrillation, LAAO with WATCHMAN resulted in an estimated ischemic stroke rate of 3.6% and a major bleeding rate of 2.4% at 2 years.
Why the study?
Does left atrial appendage occlusion with the WATCHMAN device provide safety and efficacy in Japanese patients with non-valvular atrial fibrillation?
Does left atrial appendage occlusion with the WATCHMAN device provide safety and efficacy in Japanese patients with non-valvular atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This editorial discusses the SALUTE trial, which evaluates the 2-year safety and efficacy of WATCHMAN left atrial appendage occlusion in Japanese patients with non-valvular atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Masafumi Harada (2020) conducted an editorial in Non-valvular atrial fibrillation (NVAF) (n=42). Left Atrial Appendage Occlusion (LAAO) with WATCHMAN was evaluated on Ischemic stroke rate. In a registry of 42 Japanese patients with non-valvular atrial fibrillation, LAAO with WATCHMAN resulted in an estimated ischemic stroke rate of 3.6% and a major bleeding rate of 2.4% at 2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: